Around the world on Rothschild

Tel Aviv's Sderot Rothschild will be decorated with globe sculptures this September to symbolize the globalization of the Israeli stock market.

By YONI TEITZ
July 11, 2007 08:36

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Tel Aviv's Sderot Rothschild will be decorated with globe sculptures this September to symbolize the globalization of the Israeli stock market. The Tel Aviv Stock Exchange organized the project in recognition of growth in foreign investment in Israel, and new connections between the exchange and other stock markets throughout the world. One hundred of the traded companies and member companies of the exchange will display their own globes, which will use an advanced material to have different appearances during the day and night. The globes follow a program in 2005 in which 100 fiberglass bulls lined Rothschild in celebration of the 70th anniversary of the exchange.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS